CIK: 0002026172
Total reported value
$587.7M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 9.92% | — | — | |
| 2 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 7.73% | -5.25% | EXIT | |
| 3 | ABBV | Abbvie INC | Stock-Healthcare | 7.62% | +0.89% | NEW | |
| 4 | SLNOEUR | Soleno Therapeutics INC | Stock-Other | 6.60% | -0.64% | EXIT | |
| 5 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 3.88% | — | — | |
| 6 | ACLXGBX | Arcellx INC | Stock-Other | 3.62% | — | — | |
| 7 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 3.22% | — | — | |
| 8 | TGTX | Tg Therapeutics INC | Stock-Healthcare | 3.20% | — | — | |
| 9 | INSM | Insmed INC | Stock-Healthcare | 3.15% | -1.58% | EXIT | |
| 10 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 2.86% | — | — | |
| 11 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 2.85% | — | — | |
| 12 | 2655787D | Blueprint Medicines CORP | Stock-Other | 2.40% | — | — | |
| 13 | HALO | Halozyme Therapeutics INC | Stock-Healthcare | 2.05% | — | — | |
| 14 | RYTM | Rhythm Pharmaceuticals INC | Stock-Other | 1.80% | — | — | |
| 15 | ANAB | Anaptysbio INC | Stock-Other | 1.79% | — | — | |
| 16 | SRRK | Scholar Rock Holding CORP | Stock-Other | 1.78% | — | — | |
| 17 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 1.69% | — | — | |
| 18 | KROS | Keros Therapeutics INC | Stock-Other | 1.66% | — | — | |
| 19 | BHVN | Biohaven Ltd. | Stock-Other | 1.60% | — | — | |
| 20 | ITCIEUR | Intra-cellular Therapies INC | Stock-Other | 1.57% | — | — | |
| 21 | CAPR | Capricor Therapeutics INC | Stock-Other | 1.53% | +2.01% | — | |
| 22 | ASND | Ascendis Pharma A/S | Stock-Other | 1.49% | — | — | |
| 23 | AGIO | Agios Pharmaceuticals INC | Stock-Other | 1.44% | — | — | |
| 24 | TARS | Tarsus Pharmaceuticals INC | Stock-Other | 1.43% | — | — | |
| 25 | APLSUSD | Apellis Pharmaceuticals INC | Stock-Other | 1.37% | — | — | |
| 26 | BBIO | Bridgebio Pharma INC | Stock-Healthcare | 1.18% | -4.32% | — | |
| 27 | CLDX | Celldex Therapeutics INC | Stock-Other | 1.08% | — | — | |
| 28 | RLAY | Relay Therapeutics INC | Stock-Other | 1.07% | — | — | |
| 29 | RCUS | Arcus Biosciences INC | Stock-Other | 1.06% | +0.88% | NEW | |
| 30 | APGE | Apogee Therapeutics INC | Stock-Other | 0.98% | +0.45% | — | |
| 31 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 0.95% | -0.48% | EXIT | |
| 32 | RXRX | Recursion Pharmaceuticals-a | Stock-Healthcare | 0.87% | -0.52% | EXIT | |
| 33 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 0.78% | -1.32% | — | |
| 34 | QURE | uniQure N.V. | Stock-Other | 0.76% | — | — | |
| 35 | ORIC | Oric Pharmaceuticals INC | Stock-Other | 0.74% | — | — | |
| 36 | ALT | Altimmune INC | Stock-Other | 0.62% | — | — | |
| 37 | REPL | Replimune Group INC | Stock-Other | 0.59% | +0.61% | — | |
| 38 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 0.57% | — | — | |
| 39 | VTGN | Vistagen Therapeutics INC | Stock-Other | 0.56% | — | — | |
| 40 | DNLI | Denali Therapeutics INC | Stock-Other | 0.52% | — | — | |
| 41 | NUVL | Nuvalent Inc-a | Stock-Other | 0.49% | — | — | |
| 42 | EOLS | Evolus INC | Stock-Other | 0.46% | — | — | |
| 43 | BNTX | Biontech Se-adr | Stock-Other | 0.43% | — | — | |
| 44 | VRDN | Viridian Therapeutics INC | Stock-Other | 0.41% | — | — | |
| 45 | AM6 | Amicus Therapeutics INC | Stock-Other | 0.40% | — | — | |
| 46 | JANX | Janux Therapeutics INC | Stock-Other | 0.40% | — | — | |
| 47 | OCUL | Ocular Therapeutix INC | Stock-Other | 0.38% | -1.14% | EXIT | |
| 48 | FLNA | Filana Therapeutics INC | Stock-Other | 0.38% | — | — | |
| 49 | NMRA | Neumora Therapeutics INC | Stock-Other | 0.37% | — | — | |
| 50 | PCVX | Vaxcyte INC | Stock-Other | 0.35% | +0.59% | — |